Comparison

Injectly vs Shotlee

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Injectly

This app helps you track injectable medications, including weight, peptides, and GLP. Log injections, set reminders, and view your history. Optional account syncs data across devices and offers advanced scheduling. Gain insights into medication levels and active doses.

Highlights
  • Log injectable medication doses
  • Set custom reminders
  • View injection history (calendar/list)
  • Cross-device data sync
  • Advanced scheduling options
  • Serum concentration insights
  • Data export and deletion
Features
Read full description

Injectly is the simple, yet powerful way to track your injectable medications. No ads, no subscription, and no tracking — just free help for staying on top of your regimen. Log every injection, set reminders that match your cadence, and review your history in a calendar or list. No account is needed for any of this. A free account with Apple or Google syncs your data across devices and unlocks advanced scheduling, such as on/off cycles and custom intervals. For supported medications, the Insights tab turns your logbook into a serum concentration view: an estimate of current and projected levels from the doses you've logged and your weight, how close you are to peak, and how much of the last dose is still active. Your health data is always yours: never sold, never used for advertising, and you can export or delete it anytime. Whether you're managing peptides, prescriptions, or personal health therapies, Injectly helps you log every injection, stay on schedule, and understand what's happening between each dose. Enjoy!

About

Shotlee

This app helps users track their GLP-1 and peptide medications, log injections, monitor weight loss, and gain AI-powered insights into their health journey. It offers community support and detailed analytics to understand medication effectiveness.

Highlights
  • Log GLP-1 and peptide injections
  • Track weight loss and health metrics
  • AI-powered personalized insights
  • Community chat and private support
  • Detailed analytics and trend graphs
  • Apple Health integration
Features
Read full description

Shotlee is the smartest all-in-one GLP-1 tracker for Ozempic, Wegovy, Mounjaro, Zepbound, and Retatrutide users. Log every shot, track weight loss, and unlock AI insights that show what's actually working in your transformation. Built for users of Ozempic, Wegovy, Mounjaro, Zepbound, Retatrutide, Trulicity, Saxenda, Victoza, Rybelsus, and other GLP-1 or peptide therapies — whether you're starting your journey or maintaining long-term progress. GLP-1 AND PEPTIDE TRACKER Easily log your injections, dosage amounts, and injection sites in seconds. Shotlee is optimized for a wide range of medications and peptides, including: • Semaglutide (Ozempic, Wegovy, Rybelsus) • Tirzepatide (Mounjaro, Zepbound) • Retatrutide (triple agonist — GLP-1 / GIP / glucagon) • Liraglutide (Saxenda, Victoza) • Dulaglutide (Trulicity) • Compounded semaglutide and tirzepatide • Research and biohacking peptides such as GHK-Cu, BPC-157, Melanotan MT1/MT2, Tesamorelin, Epithalon, and more. ADVANCED WEIGHT AND HEALTH LOG Apple Health integration lets you visualize progress and spot trends over time. Track weight, BMI, body measurements, calories, protein, hydration, side effects, sleep, and more. Understand exactly how your body responds to each GLP-1 or peptide dose through clear analytics and long-term data. AI-POWERED HEALTH COMPANION Get personalized insights powered by artificial intelligence. Shotlee analyzes your data to surface connections between injection timing, mood, sleep, cravings, energy, and weight fluctuations. The AI generates smart weekly summaries and helps you make informed adjustments to keep progress and motivation on track. COMMUNITY CHAT AND PRIVATE SUPPORT Join a supportive community of users on GLP-1 medications, peptides, and longevity protocols. • Group chat for real-time advice and motivation • Private DMs for one-on-one accountability • A welcoming home for those exploring StairwayToGray (STG) and peptide support groups All interactions are AI-moderated to maintain a safe, positive, and privacy-respecting environment. DETAILED ANALYTICS Turn daily logs into meaningful insights. Explore trend graphs and reports showing how your semaglutide, tirzepatide, liraglutide, or compounded regimen influences your metabolism, weight, and overall health. PRIVACY FOCUSED Your health data is sensitive. Shotlee is built with privacy and security as top priorities — your information stays protected and is never shared without your consent. HEALTH DISCLAIMER Shotlee is designed for tracking and educational purposes only. It does not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medical decisions about your medication or weight management plan. Privacy Policy: https://www.shotlee.app/privacy Terms of Service: https://www.shotlee.app/terms

Screenshots

Injectly4 screens
Shotlee4 screens

Verdict

The call

The clearest difference is in-app purchases: Injectly at none against Shotlee's 2. Injectly also leads on ads (none vs shown) and ratings volume (492 vs 17). Shotlee's advantage is review sentiment (100% vs 88%) and update cadence (every 6 days vs every 2 weeks). On price, rating, device support and iOS requirement there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Shotlee sells 2 in-app purchases, starting at $9.99 per month. Injectly asks for nothing beyond the download.

ReceptionRating · Positive reviews · Number of ratings

On the App Store both sit at effectively the same score — 4.9 for Injectly against 5.0 for Shotlee. That said, the two scores are not equally well evidenced: Injectly has 492 ratings behind it against 17, so its average is the more settled of the two. Written reviews are what separate them: 88% of Injectly's written reviews are positive against 100% of Shotlee's.

UpkeepUpdate frequency

Injectly ships an update every 2 weeks, Shotlee every 6 days. The most recent releases landed on November 5, 2026 and October 31, 2026 respectively.

Scorecard6 real differences · 4 level
Injectly versus Shotlee: the parameters behind the verdict, then further details
ParameterInjectlyShotlee
PriceFreeFree
Rating4.9 (492 ratings)5.0 (17 ratings) — better
Positive reviews88.2% of reviews100.0% of reviews — better
Number of ratings492 — better17
Update frequencyEvery 2 weeksEvery 6 days — better
AdsNo — betterYes
In-app purchasesNo — betterYes
MonetizationFree — betterFree with in-app purchases
DevicesiPhone, iPodiPhone, iPad
Requires iOS15.0 — better16.4
Further details — not scored
Size48 MB102 MB
Age rating17+17+
DeveloperMatthias GattermeierNojus Luksevicius

Customer experience

Injectly

All ratings492 ratings
Positive97.4%
Neutral1.4%
Negative1.2%
Written reviews51 reviews
Positive88.2%
Neutral11.8%
Negative0.0%

Shotlee

All ratings14 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews1 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

Injectly

No in-app purchases

2 purchases

Shotlee

Subscriptions2
  • Shotlee Pro - Monthly7 Days trial$9.991 Month
  • Shotlee Pro - Annual7 Days trial$49.991 Year

Questions

Is Injectly free?
Injectly is free to download, with no in-app purchases.
Is Shotlee free?
Shotlee is free to download, with in-app purchases available.
Which has better reviews, Injectly or Shotlee?
Shotlee is rated higher. Injectly averages 4.9 out of 5 from 492 ratings, while Shotlee averages 5.0 from 17 ratings.
Do Injectly or Shotlee have ads?
Shotlee shows ads; Injectly does not.
Which is updated more often, Injectly or Shotlee?
Injectly ships an update every 2 weeks, and Shotlee every 6 days. Most recently, Injectly was updated on November 5, 2026 and Shotlee on October 31, 2026.

Other comparisons